Subclinical signs of vascular damage relate to enhanced platelet responsiveness among nonpregnant formerly preeclamptic women

American Journal of Obstetrics and Gynecology

Volumn 194, Issue 3, 2006, Pages 855-860

  Spaanderman, Marc E A ^a   Schippers, Marianne ^b   Van Der Graaf, Fedde ^b   Thijssen, Henricus J M ^b   Liem, Ing Han ^b   Peeters, Louis L H ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MÁXIMA MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

C reactive protein; Fibronectin; Platelets; Preeclampsia; Proteinuria; Vascular function; von Willebrand factor

Indexed keywords

ADENOSINE DIPHOSPHATE; ALBUMIN; C REACTIVE PROTEIN; FIBRONECTIN; VON WILLEBRAND FACTOR;

ADULT; ALBUMINURIA; BLOOD PRESSURE; BLOOD VESSEL INJURY; BODY MASS; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HEART BEAT; HEART INDEX; HEART RATE; HEMODYNAMICS; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; PLASMA VOLUME; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; PUERPERIUM; THROMBOCYTE COUNT; THROMBOCYTE VOLUME;

ADULT; BLOOD PLATELETS; FEMALE; HUMANS; MICROCIRCULATION; PRE-ECLAMPSIA; PREGNANCY; VASCULAR DISEASES;

EID: 33644672418     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.09.012     Document Type: Conference Paper

References (32)

1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy Am J Obstet Gynecol 183 2000 S1 S22
2. M.G. Van Pampus, G.A. Dekker, H. Wolf, P.C. Huijgens, M.M. Koopman, and B.M. von Blomberg High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia Am J Obstet Gynecol 180 1999 1146 1150
3. M.J. Kupferminc, A. Eldor, N. Steinman, A. Many, A. Bar-Am, and A. Jaffa Increased frequency of genetic thrombophilia in women with complications of pregnancy N Eng J Med 340 1999 9 13
4. M.E.A. Spaanderman, T.H.A. Ekhart, J. van Eyck, E.C. Cheriex, P.W. de Leeuw, and L.L.H. Peeters Asymptomatic ex-preeclamptic women have latent hemodynamic abnormalities Am J Obstet Gynecol 182 2000 101 107
5. M.E.A. Spaanderman, T.H.A. Ekhart, J. van Eyck, P.W. de Leeuw, and L.L.H. Peeters Preeclampsia and maladaptation to pregnancy: a role for natriuretic peptide? Kidney Int 60 2001 1397 1406
6. R. Aardenburg, M.E.A. Spaanderman, T.H.A. Ekhart, H.W. van Eijndhoven, O.W.H. van der Heijden, and L.L.H. Peeters Low plasma volume following pregnancy complicated by pre-eclampsia predisposes for hypertensive disease in a next pregnancy BJOG 110 2003 1001 1006
7. M.E.A. Spaanderman, C. Willekes, A.P.G. Hoeks, T.H.A. Ekhart, R. Aardenburg, and D.A. Courtar Maternal non-pregnant vascular function correlates with subsequent fetal growth Am J Obstet Gynecol 192 2005 504 512
8. M.E.A. Spaanderman, R. Aardenburg, T.H.A. Ekhart, H.W.F. van Eyndhoven, P.W. de Leeuw, and L.L.H. Peeters Pre-pregnant prediction of recurrent preeclampsia in normotensive thrombophilic formerly preeclamptic women receiving prophylactic antithrombotic medication J Soc Gynecol Investig 12 2005 112 117
9. S.L. Janes, P.M. Kyle, C.W. Redman, and A.H. Goodall Flow cytometric detection of activated platelets in pregnant women prior to the development of preeclampsia Thromb Haemost 74 1995 1059 1063
10. A. Konijnenberg, J.A. van der Post, B.W. Mol, M.C.L. Schaap, R. Lazarov, and O.P. Bleker Can flow cytometric detection of platelet activation early in pregnancy predict the occurrence of preeclampsia: a prospective study Am J Obstet Gynecol 177 1997 434 442
11. D.P. Damron, B.A. Bouchard, R.E. Shapiro, A.L. Schonberg, and I.M. Bernstein Platelet activation, sympathetic tone, and plasma volume in nulligravid women of reproductive age Obstet Gynecol 103 2004 931 936
12. P. Hannaford, S. Ferry, and S. Hirsch Cardiovascular sequelae of toxaemia of pregnancy Heart 77 1997 154 158
13. B.J. Wilson, M.S. Watson, G.J. Prescott, S. Sunderland, D.M. Campbell, and P. Hannaford Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study BMJ 326 2003 845 852
14. S.J. Shattil, M. Cunningham, and J.A. Hoxie Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry Blood 70 1987 307 315
15. A.D. Michelson Platelets 2002 Academic Press London
16. L. Duley, D.J. Henderson-Smart, M. Knight, and J.F. King Antiplatelet agents for preventing pre-eclampsia and its complications Cochrane Database Syst Rev 1 2004 CD004659
17. H. Leitich, C. Egarter, P. Husslein, A. Kaider, and M. Schemper A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation BJOG 104 1997 450 459
18. P. Deurenberg, J.A. Weststrate, and J.C. Seidell Body mass index as a measure of body fatness: age- and sex-specific prediction formulas Br J Nutr 65 1991 105 114
19. S.C. Robson, A. Murray, I. Peart, A. Heads, and S. Hunter Reproducibility of cardiac output measurement by cross sectional and Doppler echocardiography Br Heart J 59 1988 680 684
20. P. Clausen, J.S. Jensen, G. Jensen, K. Borch-Johnsen, and B. Feldt-Rasmussen Elevated urinary albumin excretion is associated with impaired arterial dilatory capacity in clinically healthy subjects Circulation 103 2001 1869
21. R. Pedrinelli, O. Giampietro, F. Carmassi, E. Melillo, G. Dell'Omo, and G. Catapano Microalbuminuria and endothelial dysfunction in essential hypertension Lancet 344 1994 14
22. N.P. Jenkins, B.G. Keevil, I.V. Hutchinson, and N.H. Brooks Beta-blockers are associated with lower C-reactive protein concentrations in patients with coronary artery disease Am J Med 112 2002 269
23. H.C. Gerstein, J.F. Mann, Q. Yi, B. Zinman, S.F. Dinneen, B. Hoogwerf, and HOPE Study Investigators Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals JAMA 286 2001 421
24. K. Wachtell, H. Ibsen, M.H. Olsen, K. Borch-Johnsen, L.H. Lindholm, and C.E. Mogensen Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study Ann Intern Med 139 2003 901
25. M. Roest, J.D. Banga, W.M. Janssen, D.E. Grobbee, J.J. Sixma, and P.E. de Jong Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women Circulation 103 2001 3057
26. H.L. Hillege, V. Fidler, G.F. Diercks, W.H. van Gilst, D. de Zeeuw, and D.J. van Veldhuisen Prevention of Renal and Vascular End Stage Disease (PREVEND) Study Group. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population Circulation 106 2002 1777
27. K. Klausen, K. Borch-Johnsen, B. Feldt-Rasmussen, G. Jensen, P. Clausen, and H. Scharling Very low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes Circulation 110 2004 32
28. W.J. Gorgels, Y. van der Graaf, P. Hjemdahl, W. Kortlandt, H.J. Collette, and D.W. Erkelens Urinary excretions of high molecular weight beta-thromboglobulin and albumin are independently associated with coronary heart disease in women, a nested case-control study of middle-aged women in the Diagnostisch Onderzoek Mammacarcinoom (DOM) Cohort, Utrecht, Netherlands Am J Epidemiol 142 1995 1157 1164
29. A. Konijnenberg, E.W. Stokkers, J.A. van der Post, M.C. Schaap, K. Boer, and O.P. Bleker Extensive platelet activation in preeclampsia compared with normal pregnancy: enhanced expression of cell adhesion molecules Am J Obstet Gynecol 176 1997 461 469
30. A. Coomarasamy, D. Braunholtz, F. Song, R. Taylor, and K.S. Khan Individualising use of aspirin to prevent pre-eclampsia: a framework for clinical decision making BJOG 110 2003 882 888
31. E.L. Capeless, and J.F. Clapp When do cardiovascular parameters return to their preconception values? Am J Obstet Gynecol 165 Pt 1 1991 883 886
32. J. Bar, B. Kaplan, C. Wittenberg, A. Erman, G. Boner, and Z. Ben-Rafael Microalbuminuria after pregnancy complicated by pre-eclampsia Nephrol Dial Transplant 14 1999 1129 1132